Teva Pharmaceutical Industries
TEVA
$17.16
Share price
-1.38%
Change (1 day)
127.59%
Change (1 year)
Categories
P/S ratio for Teva Pharmaceutical Industries (TEVA)
P/S ratio as of June 2024 (TTM): 1.21
According to Teva Pharmaceutical Industries's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.21453. At the end of 2023 the company had a P/S ratio of 0.7477.
P/S ratio history for Teva Pharmaceutical Industries from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.7477 | 10.16% |
| 2022 | 0.6787 | 21.97% |
| 2021 | 0.5564 | -10.99% |
| 2020 | 0.6251 | -4.94% |
| 2019 | 0.6576 | -26.92% |
| 2018 | 0.8998 | 4.81% |
| 2017 | 0.8585 | -48.89% |
| 2016 | 1.68 | -44.21% |
| 2015 | 3.01 | 25.69% |
| 2014 | 2.40 | 44.02% |
| 2013 | 1.66 | 6.12% |
| 2012 | 1.57 | -19.45% |
| 2011 | 1.95 | -32.94% |
| 2010 | 2.90 | -18.91% |
| 2009 | 3.58 | 4.86% |
| 2008 | 3.41 | -14.5% |
| 2007 | 3.99 | 36.19% |
| 2006 | 2.93 | -44.67% |
| 2005 | 5.30 | 35.81% |
| 2004 | 3.90 | -18.84% |
| 2003 | 4.81 | 21.21% |
| 2002 | 3.97 | 4.34% |
| 2001 | 3.80 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 4.34 | 257.61% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.83 | 133.14% | 🇺🇸 USA |
 Sanofi SNY | 2.31 | 90.30% | 🇫🇷 France |
 Merck MRK | 5.34 | 339.76% | 🇺🇸 USA |
 AstraZeneca AZN | 5.18 | 326.75% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2.15 | 77.06% | 🇬🇧 UK |
 Dr. Reddy's RDY | 3.66 | 201.29% | 🇮🇳 India |